WNV NS5 antibody (C-Term)
-
- Target
- WNV NS5 (West Nile Virus NS5 (WNV NS5))
- Binding Specificity
- C-Term
- Reactivity
- West Nile Virus (WNV)
- Host
- Rabbit
- Clonality
- Polyclonal
- Application
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
- Cross-Reactivity
- West Nile Virus (WNV)
- Purification
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the C-terminus region of West Nile virus NS5 protein (West Nile virus (strain NY99-IC)). The exact sequence is proprietary.
- Isotype
- IgG
-
- Application Notes
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Comment
-
Positive Control: WNV-infected vero cell , WNV-infected 293T
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 2.55 mg/mL
- Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- WNV NS5 (West Nile Virus NS5 (WNV NS5))
- Alternative Name
- West Nile Virus NS5
- Background
- West Nile virus RNA-directed RNA polymerase NS5 , West Nile virus NS5 , WNV RNA-directed RNA polymerase NS5 , WNV NS5
-